Home

Ra Capital Management reported a 7.5% stake in Werewolf Therapeutics HOWL · 3,654,307 sh · amendment

Trade details

Type
5% stake report
Report
13D · amendment
Stake
7.5%
Last report
10.6% · filed 26/06/15
Shares held
3,654,307 sh
Class
Common Stock, $0.0001 par value per share
Event date
26/06/17
Filed
26/06/22

7.5% stake · −3.1pp from the last report

Stake
7.5%
Last report
10.6%
Since last report
−3.1pp

Werewolf Therapeutics trades, last 26 weeks

What else happened in Werewolf Therapeutics around then

Filed or reported within 30 days of the trade day · 05/18~07/17

Ra Capital Management's other 5% stake reports

  • Ra Capital Management

    5% stakeCorbus Pharmaceuticals Holdings

    9.9% stake

    Filed 09/30

  • Ra Capital Management

    5% stakeBetterLife Pharma

    9% stake

    Filed 09/22

  • Ra Capital Management

    5% stakeSionna Therapeutics

    14.3% stake

    Filed 09/21

  • Ra Capital Management

    5% stakeTyra Biosciences

    19.9% stake

    Filed 09/17

  • Ra Capital Management

    5% stakeJatt III Acquisition

    5.1% stake

    Filed 09/03